Literature DB >> 25716205

Severe non-traumatic bleeding, the answer is not in the blood.

Marco Tana1, Claudio Tana, Paolo Amerio, Gianfranco Vitullo, Paolo di Giosia, Concetta di Febbo, Giovanni Davì.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25716205     DOI： 10.1007/s11739-015-1210-z

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN： 1828-0447            Impact factor:   3.397


× No keyword cloud information.
  17 in total

Review 1.  Acquired hemophilia.

Authors:  L N Boggio; D Green
Journal:  Rev Clin Exp Hematol       Date:  2001-12

2.  Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors' Organisation.

Authors:  Peter W Collins; Sybil Hirsch; Trevor P Baglin; Gerard Dolan; John Hanley; Michael Makris; David M Keeling; Ri Liesner; Simon A Brown; Charles R M Hay
Journal:  Blood       Date:  2006-10-17       Impact factor: 22.113

Review 3.  Acquired hemophilia A: a concise review.

Authors:  Massimo Franchini; Giorgio Gandini; Tiziana Di Paolantonio; Guglielmo Mariani
Journal:  Am J Hematol       Date:  2005-09       Impact factor: 10.047

4.  Simultaneous occurrence of lupus anticoagulant, factor VIII inhibitor and localized pemphigoid.

Authors:  C Biron; L Durand; T Lemkecher; J Dauverchain; L Meunier; J Meynadier; J F Schved
Journal:  Am J Hematol       Date:  1996-03       Impact factor: 10.047

Review 5.  Acquired haemophilia A: a 2013 update.

Authors:  Massimo Franchini; Pier Mannuccio Mannucci
Journal:  Thromb Haemost       Date:  2013-09-05       Impact factor: 5.249

Review 6.  Acquired hemophilia associated with autoimmune bullous diseases: a report of two cases and a review of the literature.

Authors:  Shinichi Makita; Takumi Aoki; Akira Watarai; Azusa Aida; Takuji Katayama; Mikio Danbara; Masaaki Higashihara; Koji Miyazaki
Journal:  Intern Med       Date:  2013-04-01       Impact factor: 1.271

7.  Factor VIII inhibitors in two families with mild haemophilia A: structural analysis of the mutations.

Authors:  K E Knobe; B O Villoutreix; L I Tengborn; P Petrini; R C Ljung
Journal:  Haemostasis       Date:  2000 Sep-Oct

8.  Risk factors for relapse in patients with bullous pemphigoid in clinical remission: a multicenter, prospective, cohort study.

Authors:  Philippe Bernard; Ziad Reguiai; Emmanuelle Tancrède-Bohin; Nadege Cordel; Patrice Plantin; Christine Pauwels; Loïc Vaillant; Florent Grange; Marie-Aleth Richard-Lallemand; Bruno Sassolas; Jean-Claude Roujeau; Catherine Lok; Catherine Picard-Dahan; Olivier Chosidow; Fabien Vitry; Pascal Joly
Journal:  Arch Dermatol       Date:  2009-05

9.  A survey of 215 non-hemophilic patients with inhibitors to Factor VIII.

Authors:  D Green; K Lechner
Journal:  Thromb Haemost       Date:  1981-06-30       Impact factor: 5.249

10.  International recommendations on the diagnosis and treatment of patients with acquired hemophilia A.

Authors:  Angela Huth-Kühne; Francesco Baudo; Peter Collins; Jørgen Ingerslev; Craig M Kessler; Hervé Lévesque; Maria Eva Mingot Castellano; Midori Shima; Jean St-Louis
Journal:  Haematologica       Date:  2009-04       Impact factor: 9.941
View more
  2 in total

1.  Direct oral anticoagulants in factor VII deficiency patient.

Authors:  Fulvio Pomero; Laura Spadafora; Salvatore D'Agnano; Francesco Dentali; Luigi Maria Fenoglio
Journal:  Intern Emerg Med       Date:  2019-09-16       Impact factor: 3.397

Review 2.  Molecular and Clinical Issues about the Risk of Venous Thromboembolism in Older Patients: A Focus on Parkinson's Disease and Parkinsonism.

Authors:  Claudio Tana; Fulvio Lauretani; Andrea Ticinesi; Beatrice Prati; Antonio Nouvenne; Tiziana Meschi
Journal:  Int J Mol Sci       Date:  2018-04-26       Impact factor: 5.923
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.